Core Viewpoint - David Medical's stock has experienced fluctuations, with a recent decline despite a year-to-date increase, indicating potential volatility in the market [1][2]. Company Overview - David Medical, established on September 18, 1992, and listed on May 8, 2012, is located in Xiangshan, Ningbo, Zhejiang Province. The company specializes in the research, production, and sales of infant care equipment [2]. - The main revenue sources are: 51.93% from obstetric and pediatric care equipment, 45.88% from minimally invasive surgical instruments, and 2.18% from other products [2]. Stock Performance - Year-to-date, David Medical's stock price has increased by 31.03%. However, it has seen a decline of 3.17% over the last five trading days and 1.61% over the last 20 days. In contrast, the stock rose by 21.36% over the past 60 days [2]. - As of September 15, the stock price was reported at 14.64 CNY per share, with a market capitalization of 4.216 billion CNY [1]. Financial Performance - For the first half of 2025, David Medical reported a revenue of 251 million CNY, a year-on-year decrease of 5.48%. However, the net profit attributable to shareholders increased by 9.57% to 50.9767 million CNY [2]. Shareholder Information - As of August 29, the number of shareholders was 22,400, a decrease of 2.18% from the previous period. The average number of circulating shares per person increased by 2.23% to 6,417 shares [2]. - The company has distributed a total of 342 million CNY in dividends since its A-share listing, with 120 million CNY distributed in the last three years [3]. Institutional Holdings - As of June 30, 2025, among the top ten circulating shareholders, Jin Yuan Shun An Yuan Qi Ling Huo Pei Zhi Mixed Fund (004685) is the fourth largest with 900,000 shares, and Yuan Xin Yong Feng Ju You A (010469) is the fifth largest with 882,000 shares, both being new shareholders [3].

戴维医疗最新股价为15.47元，较前一交易日上涨5.38%。开盘价为15.76元，最高触及16.95元，最低下 探至15.22元，成交量为35.23万手，成交额达5.62亿元。 戴维医疗属于医疗器械板块，公司主营业务为儿产科保育设备及微创外科手术器械的研发、生产和销 售，同时布局急救手术ICU产品。2025年上半年，公司实现营业收入2.51亿元，同比下降5.48%；归属 于上市公司股东的净利润5097.67万元，同比增长9.57%。 风险提示：投资有风险，入市需谨慎。 来源:金融界 消息面上，戴维医疗披露2025年半年度报告，显示公司净利润同比增长9.57%。此外，公司第五届监事 会第十三次会议审议通过了多项议案。 资金流向方面，戴维医疗当日主力资金净流入1585.80万元，占流通市值的0.71%。近五日主力资金净流 入963.45万元，占流通市值的0.43%。 ...

8月22日，戴维医疗今日收盘15.47元，上涨5.38%，滚动市盈率PE（当前股价与前四季度每股收益总和 的比值）达到72.19倍，总市值44.55亿元。 从行业市盈率排名来看，公司所处的医疗器械行业市盈率平均56.95倍，行业中值40.49倍，戴维医疗排 名第95位。 股东方面，截至2025年8月20日，戴维医疗股东户数22900户，较上次增加400户，户均持股市值35.28万 元，户均持股数量2.76万股。 宁波戴维医疗器械股份有限公司的主营业务是儿产科保育设备、微创外科手术器械等产品的研发、生产 和销售。公司的主要产品是儿产科保育设备、微创外科手术器械、急救手术ICU产品。截至报告期末， 公司及子公司累计拥有专利257项，其中发明专利70项、实用新型专利138项、外观设计专利49项，计算 机软件著作权9项。 最新一期业绩显示，2025年半年报，公司实现营业收入2.51亿元，同比-5.48%；净利润5097.67万元，同 比9.57%，销售毛利率58.40%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)13戴维医疗72.1977.803.7244.55亿行业平均 56.9554.955.111 ...

Group 1 - As of August 21, David Medical's stock price closed at 14.68 yuan, down 0.94% from the previous trading day, with a trading volume of 75,116 hands and a transaction amount of 111 million yuan [1] - David Medical focuses on the research, production, and sales of medical devices, with its main business covering three areas: obstetric and neonatal care equipment, minimally invasive surgical instruments, and emergency surgical ICU products. The medical device manufacturing sector accounted for 98.08% of the company's revenue in the 2024 annual report [1] - On August 21, the company announced that the fifth session of the thirteenth board of directors approved the proposal regarding the full text and summary of the 2025 semi-annual report. The semi-annual report showed that in the first half of 2025, the company achieved operating revenue of 251 million yuan, a year-on-year decrease of 5.48%, while the net profit attributable to shareholders of the listed company was 50.98 million yuan, a year-on-year increase of 9.57%. Notably, the second quarter performance was strong, with a year-on-year growth of 237.4% in net profit attributable to the parent [1] Group 2 - On August 21, David Medical saw a net inflow of main funds amounting to 2.7751 million yuan, with a cumulative net inflow of 2.1627 million yuan over the past five days [2]